Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.

Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK.

Nat Immunol. 2001 May;2(5):443-51.

PMID:
11323699
2.

Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.

Dimasi N, Sawicki MW, Reineck LA, Li Y, Natarajan K, Margulies DH, Mariuzza RA.

J Mol Biol. 2002 Jul 12;320(3):573-85.

PMID:
12096910
3.

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.

Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, Spies T.

Immunogenetics. 2001 May-Jun;53(4):279-87.

PMID:
11491531
4.

Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.

Wolan DW, Teyton L, Rudolph MG, Villmow B, Bauer S, Busch DH, Wilson IA.

Nat Immunol. 2001 Mar;2(3):248-54.

PMID:
11224525
5.

NKG2D and Related Immunoreceptors.

Strong RK, McFarland BJ.

Adv Protein Chem. 2004;68:281-312. Review.

PMID:
15500864
6.

The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.

Zhang B, Wei H, Zheng X, Zhang J, Sun R, Tian Z.

Peptides. 2005 Mar;26(3):405-12.

PMID:
15652646
7.

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.

Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Peña J, Solana R, Coligan JE.

Mol Immunol. 2002 Feb;38(9):637-60. Review.

PMID:
11858820
8.

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T.

Science. 1999 Jul 30;285(5428):727-9.

9.
10.
11.

MHC class I recognition by Ly49 natural killer cell receptors.

Natarajan K, Dimasi N, Wang J, Margulies DH, Mariuzza RA.

Mol Immunol. 2002 May;38(14):1023-7. Review.

PMID:
11955594
12.
13.

An activating immunoreceptor complex formed by NKG2D and DAP10.

Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH.

Science. 1999 Jul 30;285(5428):730-2.

14.

Structural basis of MHC class I recognition by natural killer cell receptors.

Sawicki MW, Dimasi N, Natarajan K, Wang J, Margulies DH, Mariuzza RA.

Immunol Rev. 2001 Jun;181:52-65. Review.

PMID:
11513152
15.

Natural killer cell recognition of HLA class I molecules.

Brooks AG, Boyington JC, Sun PD.

Rev Immunogenet. 2000;2(3):433-48. Review.

PMID:
11256749
16.

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.

Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A.

Cancer Res. 2002 Nov 1;62(21):6178-86.

17.
18.

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

J Immunol. 2008 Nov 15;181(10):6711-9.

19.

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.

Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.

Eur J Immunol. 2003 Feb;33(2):381-91.

20.

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.

Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A.

J Immunol. 2005 Jul 15;175(2):720-9.

Items per page

Supplemental Content

Support Center